Details for Patent: 5,993,856

Summary for Patent: 5,993,856

Title:	Pharmaceutical preparations and methods for their administration
Abstract:	Formulations which have been developed for topical or local delivery intrapelvically, intraperitoneally or directly on reproductive organs of interest administration to a region such as the female reproductive system, provide for increased comfort, increased bioavailability, rapid and relatively high blood levels in the regions to be treated in the substantial absence of systemic levels of drug which might cause side effects. These formulations consist of drug micro or nanoparticles, which may be formed of drug alone or in combination with an excipient or polymeric carrier. The excipient or polymer may be used to manipulate release rates and to increase adhesion to the affected region. The particulate formulation can be applied as a dried powder, a liquid suspension or dispersion, or as a topical ointment, creme, lotion, foam or suppository.
Inventor(s):	Vanaja V. Ragavan, Gerrianne M. DiPiano
Assignee:	FEMMEPHARMA HOLDING COMPANY Inc
Application Number:	US08/971,346
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Delivery; Dosage form;

error: insufficient information

Drugs Protected by US Patent 5,993,856

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 5,993,856

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	321532
Australia	5922798
Australia	743157
Canada	2278541
Germany	69834025